Nymbl Science

Nymbl Science

Private
Denver, ColoradoHealthcare & Life Scienceshttps://nymblscience.com

Last Round

Series B

Nov 14, 2022

Total Funding Raised

$16M

Company Overview

Nymbl Science is a digital health company that provides a mobile application designed to improve balance, prevent falls, and enhance mobility for older adults.

Sector

Healthcare & Life Sciences

Verticals

InsurTech, Telemedicine, Patient Engagement, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

fall preventiondigital therapeuticsDTxbalance trainingdual-taskingMedicare Advantagevalue-based caredigital health platformsenior healthmobile health appat-risk contractspatient engagementPMPMper-member-per-monthage techbladder control programB2B2C health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nymbl Science Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nymbl Science Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BNov 14, 2022
Series ANov 16, 2020

Key People

Founding team and executive leadership

Edward Likovich

CEO

Executive Team

Nymbl Science Investors

Notable investors and investment history

InvestorRounds
Cobalt VenturesSeries B, Series A
450 VenturesSeries B

Nymbl Science Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nymbl Science Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nymbl Science's valuation, stock price, and market status.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range25
Year Founded2014
Last FundingNov 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.